Stockscreener 앱 받기
0.98
7.54%
0.0687
시장 영업 전:
.96
-0.02
-2.04%
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
Saba Capital Income & Opportunities Fund II (SABA) Stock Price, News, Quote & History - Yahoo! Finance Canada
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com UK
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Nigeria
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com India
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com South Africa
BioRestorative Therapies Announces Reverse Stock Split - Yahoo Finance
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
Neuroone Medical Technologies Corp (NASDAQ: NMTC) Stock Price, News & Analysis - kalkine.ca
NeuroOne Medical (NMTC) grants CTO 15,000 options vesting from 2027 - Stock Titan
NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan
NeuroOne Medical (NMTC) CAO awarded 12,500 stock options - Stock Titan
NeuroOne Medical | 4: Statement of changes in beneficial ownership of securities-Officer Rosa David A - Moomoo
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - minichart.com.sg
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform - Yahoo Finance
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions - Simply Wall Street
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
Nerdy Inc. Announces 1-For-15 Reverse Stock Split - Yahoo Finance
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Nigeria
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Canada
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com India
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com UK
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - The Globe and Mail
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - finance.yahoo.com
1.75%
1.62%
자본화:
|
볼륨(24시간):